CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 520770-520962 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T67983","span":{"begin":0,"end":192},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"This study investigates the dynamics of serum concentrations of the active form of TGF-beta1 during the period up to the 20th day after the onset of a MI in diabetic and non-diabetic patients."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T281","span":{"begin":0,"end":192},"obj":"Sentence"}],"text":"This study investigates the dynamics of serum concentrations of the active form of TGF-beta1 during the period up to the 20th day after the onset of a MI in diabetic and non-diabetic patients."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5009","span":{"begin":151,"end":153},"obj":"Disease"}],"attributes":[{"id":"A5009","pred":"mondo_id","subj":"T5009","obj":"http://purl.obolibrary.org/obo/MONDO_0005068"}],"text":"This study investigates the dynamics of serum concentrations of the active form of TGF-beta1 during the period up to the 20th day after the onset of a MI in diabetic and non-diabetic patients."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T2766","span":{"begin":151,"end":153},"obj":"Phenotype"}],"attributes":[{"id":"A2766","pred":"hp_id","subj":"T2766","obj":"http://purl.obolibrary.org/obo/HP_0001658"}],"text":"This study investigates the dynamics of serum concentrations of the active form of TGF-beta1 during the period up to the 20th day after the onset of a MI in diabetic and non-diabetic patients."}

    CORD-19-PD-UBERON

    {"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1087","span":{"begin":40,"end":45},"obj":"Body_part"}],"attributes":[{"id":"A1087","pred":"uberon_id","subj":"T1087","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"This study investigates the dynamics of serum concentrations of the active form of TGF-beta1 during the period up to the 20th day after the onset of a MI in diabetic and non-diabetic patients."}